ST光一(300356.SZ):擬更換2021年度審計機構
格隆匯1月6日丨ST光一(300356.SZ)公佈,基於公司2021年度財務報吿審計工作量及項目排期等實際情況,眾華事務所提出不繼續擔任公司2021年度審計機構。公司董事會同意變更久安事務所為2021年度審計機構。公司已就該事項與前後任會計師事務所進行了充分溝通,雙方已按照《中國註冊會計師審計準則第1153號—前任註冊會計師和後任註冊會計師的溝通》和其他有關要求,開展了相關工作並做好後續配合工作。截至公吿披露日,各方未對本次變更會計師事務所事宜表示異議。該事項尚需提交公司2022年第一次臨時股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.